30483738|t|A SIRT1 agonist reduces cognitive decline in type 2 diabetic rats through antioxidative and anti-inflammatory mechanisms.
30483738|a|Sirtuin 1 (SIRT1) is an NAD+-dependent protein deacetylase that is involved in cell differentiation, aging, apoptosis, physiological rhythms, metabolic regulation, oxidative stress and numerous other important biological processes. In the present study, the ability of a sirtuin-1 (SIRT1) agonist, SRT1720, to reduce cognitive decline in type 2 diabetes mellitus (T2DM) was investigated. Streptozotocin-induced male Sprague-Dawley rats were used to establish a T2DM model and the protective effect of SRT1720 and its underlying mechanisms were investigated. Body weight and fasting blood glucose (FBG) were recorded and cognitive function was measured with the Morris water maze. Levels of oxidative stress, inflammation, caspase-3 activity and nuclear factor kappaB (NF-kappaB) mRNA expression were detected with a series of commercial assay kits and reverse transcription-quantitative polymerase chain reaction, respectively. Western blot analysis was performed to determine the protein expression of NF-kappaB, endothelial nitric oxide synthase (eNOS), peroxisome proliferator-activated receptor gamma (PPARgamma), AMP-activated protein kinase (AMPK), heat shock 70 kDa protein (HSP70), SIRT1, nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase 1 (HO-1). The results revealed that SRT1720 significantly increased body weight, decreased FBG, improved cognitive function and reduced the levels of proteins associated with oxidative stress and inflammation damage in T2DM rats. Additionally, SRT1720 significantly decreased NF-kappaB p65 mRNA expression and increased eNOS and PPARgamma expression. SRT1720 significantly reduced caspase-3 activity and HSP70 protein expression, and increased p-AMPK, SIRT1, Nrf2 and HO-1 protein expression. Collectively, the results indicate that SRT1720 may reduce cognitive decline in T2DM rats through antioxidative and anti-inflammatory action via NF-kappaB and AMPK-dependent mechanisms.
30483738	2	7	SIRT1	Gene	309757
30483738	24	41	cognitive decline	Disease	MESH:D003072
30483738	45	60	type 2 diabetic	Disease	MESH:D003924
30483738	61	65	rats	Species	10116
30483738	97	109	inflammatory	Disease	MESH:D007249
30483738	122	131	Sirtuin 1	Gene	309757
30483738	133	138	SIRT1	Gene	309757
30483738	393	402	sirtuin-1	Gene	309757
30483738	404	409	SIRT1	Gene	309757
30483738	420	427	SRT1720	Chemical	MESH:C525422
30483738	439	456	cognitive decline	Disease	MESH:D003072
30483738	460	484	type 2 diabetes mellitus	Disease	MESH:D003924
30483738	486	490	T2DM	Disease	MESH:D003924
30483738	510	524	Streptozotocin	Chemical	MESH:D013311
30483738	553	557	rats	Species	10116
30483738	583	587	T2DM	Disease	MESH:D003924
30483738	623	630	SRT1720	Chemical	MESH:C525422
30483738	710	717	glucose	Chemical	MESH:D005947
30483738	830	842	inflammation	Disease	MESH:D007249
30483738	844	853	caspase-3	Gene	25402
30483738	1136	1169	endothelial nitric oxide synthase	Gene	24600
30483738	1171	1175	eNOS	Gene	24600
30483738	1178	1226	peroxisome proliferator-activated receptor gamma	Gene	25664
30483738	1228	1237	PPARgamma	Gene	25664
30483738	1240	1268	AMP-activated protein kinase	Gene	78975
30483738	1270	1274	AMPK	Gene	78975
30483738	1304	1309	HSP70	Gene	108348108
30483738	1312	1317	SIRT1	Gene	309757
30483738	1319	1362	nuclear factor erythroid 2-related factor 2	Gene	83619
30483738	1364	1368	Nrf2	Gene	83619
30483738	1374	1390	heme oxygenase 1	Gene	24451
30483738	1392	1396	HO-1	Gene	24451
30483738	1425	1432	SRT1720	Chemical	MESH:C525422
30483738	1585	1597	inflammation	Disease	MESH:D007249
30483738	1608	1612	T2DM	Disease	MESH:D003924
30483738	1613	1617	rats	Species	10116
30483738	1633	1640	SRT1720	Chemical	MESH:C525422
30483738	1709	1713	eNOS	Gene	24600
30483738	1718	1727	PPARgamma	Gene	25664
30483738	1740	1747	SRT1720	Chemical	MESH:C525422
30483738	1770	1779	caspase-3	Gene	25402
30483738	1793	1798	HSP70	Gene	108348108
30483738	1835	1839	AMPK	Gene	78975
30483738	1841	1846	SIRT1	Gene	309757
30483738	1848	1852	Nrf2	Gene	83619
30483738	1857	1861	HO-1	Gene	24451
30483738	1922	1929	SRT1720	Chemical	MESH:C525422
30483738	1941	1958	cognitive decline	Disease	MESH:D003072
30483738	1962	1966	T2DM	Disease	MESH:D003924
30483738	1967	1971	rats	Species	10116
30483738	2003	2015	inflammatory	Disease	MESH:D007249
30483738	2041	2045	AMPK	Gene	78975
30483738	Positive_Correlation	MESH:C525422	309757
30483738	Negative_Correlation	MESH:C525422	108348108
30483738	Positive_Correlation	MESH:C525422	25664
30483738	Positive_Correlation	MESH:C525422	78975
30483738	Association	MESH:D007249	78975
30483738	Positive_Correlation	MESH:C525422	24451
30483738	Positive_Correlation	MESH:C525422	83619
30483738	Positive_Correlation	MESH:C525422	24600
30483738	Association	MESH:D003072	78975
30483738	Negative_Correlation	MESH:C525422	MESH:D003072
30483738	Association	MESH:D007249	309757
30483738	Negative_Correlation	MESH:C525422	25402
30483738	Positive_Correlation	MESH:D013311	MESH:D003924
30483738	Association	MESH:D003072	309757
30483738	Association	MESH:D003924	309757
30483738	Negative_Correlation	MESH:C525422	MESH:D003924
30483738	Negative_Correlation	MESH:C525422	MESH:D007249

